Home » Newsletters » BioWorld

BioWorld

Feb. 19, 1992

View Archived Issues

AMYLIN SPEEDS UP TRIAL PLANS

NVX VACCINE DEAL WITH DANES

APPLIED BIOSYSTEMS SETTLES PATENT CLAIM

HEMACARE REGISTERS SHARES

NOVEN FILES TO SELL 2.5M SHARES

TRIALS START ON BLOOD SUBSTITUTE

EPITOPE, SMITHKLINE TO END COLLABORATION

BARD SEEKS TRIALS OF BIOMATRIX GEL

INCYTE PATENT FOR SEPSIS TREATMENT

DRUG BLOCKS HIV ENTRY INTO CELLS

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 11, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 9, 2026
Skape Bio unlocks GPCR targets with de novo-designed miniproteins
BioWorld
Modulating G protein-coupled receptors (GPCRs) is one of the major challenges in biomedicine. These are flexible proteins with small, deep binding pockets. The...
New 5-HT2C receptor agonists reported in Hansoh patent
BioWorld Science
Researchers from Jiangsu Hansoh Pharmaceutical Group Co. Ltd. and Shanghai Hansoh Biomedical Co. Ltd. have disclosed tricyclic compounds acting as 5-HT2C receptor...
Pre-disease plasma signature may help redefine lung cancer risk
BioWorld
Researchers have identified a 14-protein blood signature that can predict lung cancer risk as much as five years before diagnosis, and the findings could help...